Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ·Healthcare·Biotechnology
$11.41
-1.55%
Mkt Cap $958.19M
Analyst Ratings
Buy
3
Hold
0
Sell
0
Price Target (15 analysts)
$23.33
Range $16.00 – $28.00
Implied Upside
+104.5%
Consensus $23.33 vs current $11.41
NASDAQ·Healthcare·Biotechnology
$11.41
-1.55%
Mkt Cap $958.19M
Buy
3
Hold
0
Sell
0
Price Target (15 analysts)
$23.33
Range $16.00 – $28.00
+104.5%
Consensus $23.33 vs current $11.41